High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: Implications for in utero and ex utero gene therapy

Fetal Diagnosis and Therapy

Volumn 16, Issue 5, 2001, Pages 299-307

  Ohkubo, Tatsuo ^a   Bárcena, Alicia ^a   Smith, Clayton A ^b   Harrison, Michael R ^a   Muench, Marcus O ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Fetal tissues; Gene therapy; Hematopoietic stem cells; Retroviral vectors

Indexed keywords

CD14 ANTIGEN; CD15 ANTIGEN; CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; FIBRINOGEN RECEPTOR; GLYCOPHORIN A; NERVE GROWTH FACTOR RECEPTOR; PROTAMINE SULFATE;

ARTICLE; BIRTH DEFECT; BLOOD CELL; BLOOD DISEASE; CELL ISOLATION; CELL STIMULATION; CENTRIFUGATION; CONTROLLED STUDY; FETUS; FETUS LIVER; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; MARKER GENE; PRIORITY JOURNAL; PROGENY; STEM CELL;

ADP-RIBOSYL CYCLASE; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; LIVER; MEMBRANE GLYCOPROTEINS; NAD+ NUCLEOSIDASE; RECEPTORS, NERVE GROWTH FACTOR; RETROVIRIDAE; STEM CELL FACTOR; TRANSFECTION;

EID: 0034880427     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053932     Document Type: Article

References (44)

1. In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers
2. In utero gene therapy: Transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses
3. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations
4. Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients
5. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells
6. Delayed targeting of cytokine-nonresponsive human bone marrow CD34(+) cells with retrovirus-mediated gene transfer enhances transduction efficiency and long-term expression of transduced genes
7. Retrovirus-mediated gene transfer into human CD34+38 low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic severe combined immunodeficiency mice in vivo
8. Successful reconstitution of human hematopoiesis in the SCID-hu mouse by genetically modified, highly enriched progenitors isolated from fetal liver
9. FLK-2/FLT-3 ligand (FL) regulates the growth of early myeloid progenitors isolated from human fetal liver
10. - fetal liver cells
11. Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro
12. +/++ cells for transplantation
13. + T lymphocytes
14. Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells
15. Expression of CD33, CD38 and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential
16. Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver
17. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow
18. Ontogeny-related changes in proliferative potential of human hematopoietic cells
19. Cell-surface markers for assessing gene transfer into human hematopoietic cells
20. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells
21. Centrifugal enhancement of human immunodeficiency virus type 1 infection and human cytomegalovirus gene expression in human primary monocyte/macrophages in vitro
22. Improved methods of retroviral vector transduction and production for gene therapy
23. Centrifugal enhancement of retroviral mediated gene transfer
24. Phenotypic and functional evidence for the expression of CD4 by hematopoietic stem cells isolated from human fetal liver
25. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy
26. Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer
27. The effects of human serum and cerebrospinal fluid on retroviral vectors and packaging cell lines
28. Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions
29. Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium
30. Protamine sulfate as an effective alternative to polybrene in retro-viral-mediated gene-transfer: Implications for human gene therapy
31. Developmental-stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells
32. Up-regulation of amphotrophic retroviral receptor expression in human peripheral blood CD34+ cells
33. Interaction of vesicular stomatitis virus-G pseudotyped retrovirus with CD34+ and CD34+ CD38- hematopoietic progenitor cells
34. Flt3 ligand induces proliferation of quiescent human bone marrow CD34+ CD38- cells and maintains progenitor cells in vitro
35. Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand
36. Establishment of a tissue bank for fetal stem cell transplantation
37. Long-term storage of human fetal haematopoietic progenitor cells and their subsequent reconstitution. Implications for in utero transplantation
38. Fetal bone marrow as a source of stem cells for in utero or postnatal transplantation
39. Comparative study of hemopoietic precursors from fetal and adult bone marrow: Utilization of stem cells derived from miscarriages
40. Prenatal gene transfer: Scientific, medical and ethical issues. A report of the recombinant DNA advisory committee
41. Subpopulations of CD34-positive haemopoietic progenitors in fetal blood
42. Circulating hematopoietic stem cell populations in human fetuses: Implications for fetal gene therapy and alterations with in utero red cell transfusion
43. Circulating progenitor cells in human ontogenesis: Response to growth factors and replating potential
44. Gene transfer into fetal baboon hematopoietic progenitor cells